WB | 1/1000-1/2000 | Human,Mouse,Rat |
IF | 1/20-1/50 | Human,Mouse,Rat |
IHC | 咨询技术 | Human,Mouse,Rat |
ICC | 技术咨询 | Human,Mouse,Rat |
FCM | 1/20-1/100 | Human,Mouse,Rat |
Elisa | 咨询技术 | Human,Mouse,Rat |
Aliases | Fos L2; Fosl2; FRA 2;;FRA2 |
WB Predicted band size | Calculated MW: 35 kDa ; Observed MW: 45 kDa |
Host/Isotype | Rabbit IgG |
Antibody Type | Primary antibody |
Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
Species Reactivity | Human,Mouse,Rat |
Immunogen | A synthesized peptide derived from human FRA2 |
Formulation | Purified antibody in PBS with 0.05% sodium azide,0.05% BSA and 50% glycerol. |
+ +
以下是关于FRA2(FOSL2)抗体的3篇参考文献的简要总结:
1. **文献名称**:*"FRA2 expression and its role in fibrosis-related gene transcription"*
**作者**:Smith J, et al.
**摘要**:该研究利用FRA2抗体进行染色质免疫沉淀(ChIP)实验,发现FRA2蛋白通过结合胶原蛋白基因启动子区调控纤维化过程,为肺纤维化治疗提供潜在靶点。
2. **文献名称**:*"Antibody validation for FRA2 in immunohistochemical analysis of tumor tissues"*
**作者**:Lee S, et al.
**摘要**:作者验证了FRA2抗体的特异性,发现其在多种肿瘤组织中高表达,且与癌症侵袭性相关,提示FRA2可能作为肿瘤预后标志物。
3. **文献名称**:*"FOSL2/FRA2 regulates angiogenesis through VEGF signaling pathway"*
**作者**:Wang Y, et al.
**摘要**:通过FRA2抗体阻断实验,研究证实FRA2通过调控血管内皮生长因子(VEGF)的表达促进血管生成,影响肿瘤微环境。
**备注**:以上文献信息为模拟示例,实际引用时需通过PubMed或Web of Science等平台检索真实文献(FRA2相关研究多集中于肿瘤、纤维化及发育生物学领域)。
The FRA2 antibody targets FOS-related antigen 2 (Fra-2), a member of the FOS protein family, which includes c-Fos, Fra-1. and FosB. Fra-2 forms heterodimers with JUN family proteins to create the activator protein 1 (AP-1) transcription factor complex. AP-1 regulates genes involved in cell proliferation, differentiation, apoptosis, and stress responses. Unlike other FOS proteins, Fra-2 exhibits distinct regulatory mechanisms and tissue-specific roles. It is constitutively expressed in certain tissues, such as immune cells and epithelial tissues, and plays critical roles in embryonic development, bone homeostasis, and angiogenesis. Dysregulation of Fra-2 is implicated in pathological conditions, including cancer metastasis, fibrosis, and autoimmune diseases.
The FRA2 antibody is widely used in research to detect Fra-2 expression via techniques like Western blotting, immunohistochemistry, and immunofluorescence. It aids in studying Fra-2’s role in tumor progression, epithelial-mesenchymal transition (EMT), and inflammatory pathways. Studies highlight its involvement in modulating extracellular matrix remodeling and immune responses, making it a potential therapeutic target. Commercial FRA2 antibodies are typically validated for specificity across human, mouse, and rat samples, with applications in both basic research and clinical biomarker discovery. Understanding Fra-2’s dual roles in homeostasis and disease underscores its importance in cellular signaling research.
×